Search
× Search

Baza informacij za delovanje Partnerjev Mreže Modro Poslovanje

0 0

CELEX:62019TJ0520_INF:           Arrêt du Tribunal (neuvième chambre) du 9 février 2022.#Heitec AG contre Office de l’Union européenne pour la propriété intellectuelle.#Marque de l’Union européenne – Procédure de déchéance – Marque de l’Union européenne verbale HEITEC – Absence de prise en compte d’éléments de preuve présentés devant la division d’annulation et devant la chambre de recours – Article 95, paragraphe 2, du règlement (UE) 2017/1001 – Absence d’usage sérieux de la marque – Article 51, paragraphe 1, sous a), du règlement (CE) no 207/2009 [devenu article 58, paragraphe 1, sous a), du règlement 2017/1001] – Règle 40, paragraphe 5, du règlement (CE) no 2868/95 [devenue article 19, paragraphe 1, du règlement délégué (UE) 2018/625].#Affaire T-520/19.

This document does not exist in English.
0 0

CELEX:62019TJ0525_RES: Judgment of the General Court (First Chamber) of 21 April 2021.#Intering Sh.p.k and Others v European Commission.#Public contracts – Tendering procedure – Reduction of dust and nitrogen oxide emissions at the Kosovo B thermal power plant, Units B1 and B2 – Rejection of the application – Application for annulment submitted in the reply – New claims – Manifest inadmissibility – Amendment of the selection criteria during the procedure – Equal treatment.#Case T-525/19.

0 0

CELEX:62019TJ0543_RES: Judgment of the General Court (Tenth Chamber, Extended Composition) of 14 April 2021.#Romania v European Commission.#Cohesion Fund and ERDF – Article 139(6) of Regulation (EU) No 1303/2013 – Temporal application of an increased co-financing rate adopted after submission of the final application for an interim payment but before acceptance of the accounts – Legitimate expectation – Obligation to state reasons – Principle of good administration.#Case T-543/19.

0 0

CELEX:62019TJ0549_RES: Judgment of the General Court (Tenth Chamber) of 23 September 2020 (Extracts).#Medac Gesellschaft für klinische Spezialpräparate mbH v European Commission.#Medicinal products for human use – Orphan medicinal products – Application for marketing authorisation for the medicinal product Trecondi-treosulfan – Decision to remove a medicinal product from the Register of Orphan Medicinal Products – Article 3(1)(b) of Regulation (EC) No 141/2000 – Concept of ‘satisfactory method’ – Article 5(12)(b) of Regulation No 141/2000 – Error of law.#Case T-549/19.

RSS
First787788789790792794795796Last

Poišči članke o davkih v bazi Modro poslovanje

Terms Of UsePrivacy StatementCopyright 2014-2014 by Srobotnik d.o.o.
Back To Top